P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO Sponsors
- Glead
- Pfizer
- Roche
- Amgen
- Astellas
- Bristol-Myers Squibb
- Arven
- Johnson Johnson
- Merck
- Novartis
- Omnigen
- Mustafa Nevzat
- TEVA
- Trpharm
Relationship Between Disease Activation, Serum Erythrocyte Sediment Level and C-reactive Protein Level in Rheumatoid Arthritis Patients Receiving Anti-Tumor Necrosis Factor Alpha Treatment